PLIANT THERAPEUTICS, INC. Stock Split Ratio
PLIANT THERAPEUTICS, INC. (PLRX) reported Stock Split Ratio of 13.99% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-01
- PLIANT THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2020 was 13.99%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | 13.99% 10-K · filed 2021-03-16 | ||||
| 2020-09-30 | 13.99% 10-Q · filed 2020-11-10 | ||||
| 2020-06-30 | 13.99% 10-Q · filed 2020-08-11 | ||||
| 2020-05-31 | 13.99% 10-K · filed 2021-03-16 | ||||
| 2020-05-22 | 13.99% 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |